We constructed a nomogram to predict 1‐, 2‐, and 3‐year survival probabilities for glioma patients by incorporating WHO grade, age, 1p/19q codeletion status, IDH mutation status, and SuperPC‐derived risk score (Figure 11A,C). This evidence concerns the gene IDH1 and central nervous system cancer.